.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Mallinckrodt
Fuji
Argus Health
Colorcon
US Department of Justice
AstraZeneca
QuintilesIMS
Dow
Fish and Richardson

Generated: June 24, 2017

DrugPatentWatch Database Preview

Chlordiazepoxide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlordiazepoxide hydrochloride and what is the scope of chlordiazepoxide hydrochloride patent protection?

Chlordiazepoxide hydrochloride
is the generic ingredient in six branded drugs marketed by Hikma Pharms Llc, Roxane, Mylan, Valeant Pharms Llc, Teva, Alra, Vangard, Ascot, Impax Labs, Abbott, Barr, Mast Mm, Ferrante, Sandoz, Usl Pharma, Lederle, Pioneer Pharms, Rachelle, Halsey, Purepac Pharm, Ivax Sub Teva Pharms, Upsher-smith Labs, Valeant Pharm Intl, Parke Davis, Watson Labs, Superpharm, and Valeant Pharms, and is included in eighty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for chlordiazepoxide hydrochloride. Seventeen suppliers are listed for this compound.

Summary for Generic Name: chlordiazepoxide hydrochloride

Tradenames:6
Patents:1
Applicants:27
NDAs:80
Drug Master File Entries: see list8
Suppliers / Packagers: see list17
Bulk Api Vendors: see list17
Clinical Trials: see list2,250
Patent Applications: see list2,841
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:chlordiazepoxide hydrochloride at DailyMed

Pharmacology for Ingredient: chlordiazepoxide hydrochloride

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL084706-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Alra
LYGEN
chlordiazepoxide hydrochloride
CAPSULE;ORAL085108-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Mylan
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL084887-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sandoz
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL084920-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Hikma Pharms Llc
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL085014-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: chlordiazepoxide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl
LIBRIUM
chlordiazepoxide hydrochloride
CAPSULE;ORAL012249-003Approved Prior to Jan 1, 19824,316,897► Subscribe
Valeant Pharms Llc
LIBRIUM
chlordiazepoxide hydrochloride
INJECTABLE;INJECTION012301-001Approved Prior to Jan 1, 19824,316,897► Subscribe
Valeant Pharm Intl
LIBRIUM
chlordiazepoxide hydrochloride
CAPSULE;ORAL012249-001Approved Prior to Jan 1, 19824,316,897► Subscribe
Valeant Pharm Intl
LIBRIUM
chlordiazepoxide hydrochloride
CAPSULE;ORAL012249-002Approved Prior to Jan 1, 19824,316,897► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Harvard Business School
QuintilesIMS
Baxter
Covington
Medtronic
Chinese Patent Office
Queensland Health
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot